These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 28657124)
1. LARGE-PD: Examining the genetics of Parkinson's disease in Latin America. Zabetian CP; Mata IF; Mov Disord; 2017 Sep; 32(9):1330-1331. PubMed ID: 28657124 [No Abstract] [Full Text] [Related]
2. LRRK2 and the new era of Parkinson's disease research. The Lancet Neurology Lancet Neurol; 2016 Nov; 15(12):1195. PubMed ID: 27751534 [No Abstract] [Full Text] [Related]
3. Association of LRRK2 and GBA mutations in a Brazilian family with Parkinson's disease. Spitz M; Pereira JS; Nicareta DH; Abreu Gde M; Bastos EF; Seixas TL; Pimentel MM Parkinsonism Relat Disord; 2015 Jul; 21(7):825-6. PubMed ID: 25952961 [No Abstract] [Full Text] [Related]
4. Leucine-Rich Repeat Kinase (LRRK2) Genetics and Parkinson's Disease. Monfrini E; Di Fonzo A Adv Neurobiol; 2017; 14():3-30. PubMed ID: 28353276 [TBL] [Abstract][Full Text] [Related]
6. Association of LRRK2 Haplotype With Age at Onset in Parkinson Disease. Xiao B; Deng X; Ng EY; Allen JC; Lim SY; Ahmad-Annuar A; Tan EK JAMA Neurol; 2018 Jan; 75(1):127-128. PubMed ID: 29131875 [TBL] [Abstract][Full Text] [Related]
14. G2019S mutation of the leucine-rich repeat kinase 2 gene in a cohort of Egyptian patients with Parkinson's disease. Hashad DI; Abou-Zeid AA; Achmawy GA; Allah HM; Saad MA Genet Test Mol Biomarkers; 2011 Dec; 15(12):861-6. PubMed ID: 21699405 [TBL] [Abstract][Full Text] [Related]
15. The G2019S LRRK2 mutation is uncommon amongst Greek patients with sporadic Parkinson's disease. Kalinderi K; Fidani L; Bostantjopoulou S; Katsarou Z; Kotsis A Eur J Neurol; 2007 Oct; 14(10):1088-90. PubMed ID: 17880562 [TBL] [Abstract][Full Text] [Related]
17. LRRK2 G2019S Mutation Inhibits Degradation of α-Synuclein in an In Vitro Model of Parkinson's Disease. Hu D; Niu JY; Xiong J; Nie SK; Zeng F; Zhang ZH Curr Med Sci; 2018 Dec; 38(6):1012-1017. PubMed ID: 30536063 [TBL] [Abstract][Full Text] [Related]
18. Generation of an induced pluripotent stem cell line (CSC-41) from a Parkinson's disease patient carrying a p.G2019S mutation in the LRRK2 gene. Marote A; Pomeshchik Y; Collin A; Goldwurm S; Lamas NJ; Pinto L; Salgado AJ; Roybon L Stem Cell Res; 2018 Apr; 28():44-47. PubMed ID: 29414418 [TBL] [Abstract][Full Text] [Related]
19. LRRK2: bridging the gap between sporadic and hereditary Parkinson's disease. Elbaz A Lancet Neurol; 2008 Jul; 7(7):562-4. PubMed ID: 18539536 [No Abstract] [Full Text] [Related]
20. Autosomal dominant Parkinson's disease: Incidence of mutations in LRRK2, SNCA, VPS35 and GBA genes in Brazil. Abreu GM; Valença DC; Campos M; da Silva CP; Pereira JS; Araujo Leite MA; Rosso AL; Nicaretta DH; Vasconcellos LF; da Silva DJ; Della Coletta MV; Dos Santos JM; Gonçalves AP; Santos-Rebouças CB; Pimentel MM Neurosci Lett; 2016 Dec; 635():67-70. PubMed ID: 27777137 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]